1733. Voriconazole Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplant: How Much Is Enough, Are Low Voriconazole Levels Associated With Opportunistic Infections, and What Are the Reasons for Discontinuation?

BACKGROUND: Patients who undergo allogeneic hematopoietic stem cell transplantation (alloHSCT) are at increased risk for invasive fungal infections with associated high morbidity and mortality that necessitates the use of prophylactic antifungals. Voriconazole is commonly used for prophylaxis, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjivassiliou, Giorgos, Rummage, Claire, Hoesley, Craig, Brown, Matthew L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809616/
http://dx.doi.org/10.1093/ofid/ofz360.1596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809616/
http://dx.doi.org/10.1093/ofid/ofz360.1596

Ejemplares similares